Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 839

1.

Standard genotyping overestimates transmission of Mycobacterium tuberculosis among immigrants in a low incidence country.

Stucki D, Ballif M, Egger M, Furrer H, Altpeter E, Battegay M, Droz S, Bruderer T, Coscolla M, Borrell S, Zürcher K, Janssens JP, Calmy A, Mazza Stalder J, Jaton K, Rieder HL, Pfyffer GE, Siegrist HH, Hoffmann M, Fehr J, Dolina M, Frei R, Schrenzel J, Böttger EC, Gagneux S, Fenner L; Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups.

J Clin Microbiol. 2016 May 18. pii: JCM.00126-16. [Epub ahead of print]

PMID:
27194683
2.

Gelatin methacrylamide as coating material in cell culture.

Egger M, Tovar GE, Hoch E, Southan A.

Biointerphases. 2016 Jun 13;11(2):021007. doi: 10.1116/1.4949545.

PMID:
27177620
3.

Changes in the primary outcome in Ebola vaccine trial--Authors' reply.

Kieny MP, Longini IM, Henao-Restrepo AM, Watson CH, Egger M, Edmunds WJ.

Lancet. 2016 Apr 9;387(10027):1509-10. doi: 10.1016/S0140-6736(16)00686-3. Epub 2016 Apr 7. No abstract available.

PMID:
27115974
4.

Record linkage to correct under-ascertainment of cancers in HIV cohorts: the Sinikithemba HIV clinic linkage project.

Sengayi M, Spoerri A, Egger M, Kielkowski D, Crankshaw T, Cloete C, Giddy J, Bohlius J.

Int J Cancer. 2016 Apr 21. doi: 10.1002/ijc.30154. [Epub ahead of print]

PMID:
27098265
5.

Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment.

Xiao D, Barry S, Kmetz D, Egger M, Pan J, Rai SN, Qu J, McMasters KM, Hao H.

Cancer Lett. 2016 Jul 1;376(2):318-27. doi: 10.1016/j.canlet.2016.03.050. Epub 2016 Apr 7.

PMID:
27063098
6.

Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.

Begré L, Rohner E, Mbulaiteye SM, Egger M, Bohlius J.

Int J Cancer. 2016 Apr 7. doi: 10.1002/ijc.30129. [Epub ahead of print]

PMID:
27062038
7.

Absence of Active Hepatitis C Virus Infection in Human Immunodeficiency Virus Clinics in Zambia and Mozambique.

Wandeler G, Mulenga L, Hobbins M, Joao C, Sinkala E, Hector J, Aly M, Chi BH, Egger M, Vinikoor MJ.

Open Forum Infect Dis. 2016 Mar 2;3(2):ofw049. doi: 10.1093/ofid/ofw049. eCollection 2016 Mar.

8.

Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.

Wandeler G, Musukuma K, Zürcher S, Vinikoor MJ, Llenas-García J, Aly MM, Mulenga L, Chi BH, Ehmer J, Hobbins MA, Bolton-Moore C, Hoffmann CJ, Egger M; IeDEA-Southern Africa.

PLoS One. 2016 Mar 31;11(3):e0152043. doi: 10.1371/journal.pone.0152043. eCollection 2016.

9.

[Sputum purulence: practical guide to introduce antibiotic therapy].

Egger M, Raetzo MA, Kherad O.

Rev Med Suisse. 2016 Feb 3;12(504):250, 252-5. French.

PMID:
26999994
10.

Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia.

Egger ME, Myers JA, Arnold FW, Pass LA, Ramirez JA, Brock GN.

BMC Med Inform Decis Mak. 2016 Mar 15;16:34. doi: 10.1186/s12911-016-0270-y.

11.

Tuberculosis in Cape Town: An age-structured transmission model.

Blaser N, Zahnd C, Hermans S, Salazar-Vizcaya L, Estill J, Morrow C, Egger M, Keiser O, Wood R.

Epidemics. 2016 Mar;14:54-61. doi: 10.1016/j.epidem.2015.10.001. Epub 2015 Oct 20.

12.

Developing a point-of-care electronic medical record system for TB/HIV co-infected patients: experiences from Lighthouse Trust, Lilongwe, Malawi.

Tweya H, Feldacker C, Gadabu OJ, Ng'ambi W, Mumba SL, Phiri D, Kamvazina L, Mwakilama S, Kanyerere H, Keiser O, Mwafilaso J, Kamba C, Egger M, Jahn A, Simwaka B, Phiri S.

BMC Res Notes. 2016 Mar 5;9(1):146. doi: 10.1186/s13104-016-1943-4.

13.

NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.

Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M, Han M, Thornton AM, Zhang H, Egger M, Luo J, Felsher DW, McVicar DW, Weber A, Heikenwalder M, Greten TF.

Nature. 2016 Mar 10;531(7593):253-7. doi: 10.1038/nature16969. Epub 2016 Mar 2.

PMID:
26934227
14.

Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors.

Mueller T, Egger M, Leitner I, Gabriel C, Haltmayer M, Dieplinger B.

Clin Chim Acta. 2016 May 1;456:19-23. doi: 10.1016/j.cca.2016.02.014. Epub 2016 Feb 24.

15.

Incidence of AIDS-defining and Other Cancers in HIV-positive Children in South Africa: Record Linkage Study.

Bohlius J, Maxwell N, Spoerri A, Wainwright R, Sawry S, Poole J, Eley B, Prozesky H, Rabie H, Garone D, Technau KG, Maskew M, Davies MA, Davidson A, Stefan DC, Egger M; for IeDEA-Southern Africa.

Pediatr Infect Dis J. 2016 Jun;35(6):e164-70. doi: 10.1097/INF.0000000000001117.

PMID:
26906162
16.

The impact of acute and chronic strenuous exercise on pelvic floor muscle strength and support in nulliparous healthy women.

Middlekauff ML, Egger MJ, Nygaard IE, Shaw JM.

Am J Obstet Gynecol. 2016 Feb 17. pii: S0002-9378(16)00329-X. doi: 10.1016/j.ajog.2016.02.031. [Epub ahead of print]

PMID:
26899909
17.

When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study.

Caniglia EC, Sabin C, Robins JM, Logan R, Cain LE, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RR, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Olson A, Justice AC, Tate JP, Bucher HC, Egger M, Touloumi G, Sterne JA, Costagliola D, Saag M, Hernán MA; Center for AIDS Research Network of Integrated Clinical Systems and the HIV-CAUSAL Collaboration.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):214-21. doi: 10.1097/QAI.0000000000000956.

PMID:
26895294
18.

Tuberculosis Mortality and Living Conditions in Bern, Switzerland, 1856-1950.

Zürcher K, Ballif M, Zwahlen M, Rieder HL, Egger M, Fenner L.

PLoS One. 2016 Feb 16;11(2):e0149195. doi: 10.1371/journal.pone.0149195. eCollection 2016.

19.

Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.

Kimbrough CW, Egger ME, McMasters KM, Stromberg AJ, Martin RC, Philips P, Scoggins CR.

J Am Coll Surg. 2016 Apr;222(4):357-63. doi: 10.1016/j.jamcollsurg.2015.12.042. Epub 2016 Jan 14.

PMID:
26875070
20.

Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.

McMasters KM, Egger ME, Edwards MJ, Ross MI, Reintgen DS, Noyes RD, Martin RC 2nd, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Davidson BS, Gershenwald JE, Hagendoorn LJ, Stromberg AJ, Scoggins CR.

J Clin Oncol. 2016 Apr 1;34(10):1079-86. doi: 10.1200/JCO.2015.63.3776. Epub 2016 Feb 8.

PMID:
26858331
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk